Techne acquires Mass. firm for $104M

  • Article by: STEVE ALEXANDER , Star Tribune
  • Updated: June 18, 2013 - 8:33 PM

Mass.-based company offers products to verify the proper operation of certain medical devices.

 

Biotech firm Techne Corp. has acquired Massachusetts-based Bionostics Holdings Ltd. for $104 million in cash.

Techne, based in Minneapolis, makes controls used in hospitals and laboratories to check the accuracy of blood analysis instruments. Bionostics, based in Devens, Mass., offers control products for verifying the proper operation of medical devices used for blood glucose and blood gas testing.

The acquisition is expected to be “slightly accretive” to Techne’s fiscal 2014 net earnings.

“The addition of Bionostics adds capabilities in exciting new areas like [blood] coagulation, and expands our controls portfolio,” said Techne CEO Charles Kummeth.

 

Steve Alexander• 612-673-4553

  • get related content delivered to your inbox

  • manage my email subscriptions

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

 
Close